Htn
Hypertension Management
search
Hypertension Management
See Also
Hypertension
Hypertension Causes
Hypertension Evaluation
Hypertension Evaluation History
Evaluation Exam
Hypertension Evaluation Labs
Isolated Systolic Hypertension
Hypertension Management
Hypertension Risk Stratification
Resistant Hypertension
Antihypertensive Selection
Hypertension Management for Specific Comorbid Diseases
Hypertension Management for Specific Populations
Hypertension Management for Specific Emergencies
Hypertension in Children
Hypertension in Infants
Hypertension in Pregnancy
Hypertension in Athletes
Hypertension in the Elderly
Management
Gene
ral Guidelines
See patients back at one month after starting agent
Significantly improves compliance
BP requires 1 month on agent to equilibrate
Maximize compliance
Work with patients to reduce adverse effects
Switch to other agents if adverse effects significant
Do not be overzealous
Risk of overcorrection of
Blood Pressure
Avoid lowering diastolic pressure <70 mmHg
Greater tolerance for elevated BP with increased age
Study of 484 Swedish men over 70 from 1982-1992
Risk if Diastolic
Blood Pressure
lowered below 90
Increased cardiac event risk 3.9x
Controlled for confounding factors
Reference
Merlo (1996) BMJ 313:457-61 [PubMed]
Consider nighttime dosing
Advantages
Associated with decreased cardiovascular events and improve
Blood Pressure
control
Hermida (2019) Eur Heart J +PMID:31641769 [PubMed]
Benefit may best in patients who do not dip their
Blood Pressure
overnight
Non-dippers: Older,
Diabetes Mellitus
,
Chronic Kidney Disease
,
Resistant Hypertension
Consider 24 hour ambulatory monitoring to define unclear cases
Disadvantages
Risk of non-compliance
Do not switch to nighttime dose if patient can not remember that dose
Risk of
Orthostatic Hypotension
and
Fall Risk
at night
Indications to switch at least one medication to nighttime dosing
Three or more antihypertensives used
Best medications for nighttime dosing
Angiotensin Converting Enzyme Inhibitor
s (
ACE Inhibitor
s)
Angiotensin Receptor Blocker
s
Calcium Channel Blocker
s
Alpha Blockers
Beta Blocker
s
Avoid
Diuretic
s over night
References
(2012) Prescr Lett 19(1): 4
Hermida (2011) J Am Soc Nephrol 22: 2313-21 [PubMed]
Management
Choose agents with best outcome data
Medications that prevent
Hypertension
vascular sequelae
Diuretic
s
ACE Inhibitor
s
Calcium Channel Blocker
s
Beta-Blocker
s
Indicated in patients with known
Coronary Artery Disease
or chronic, stable
Systolic Dysfunction
Medications that prevent
Left Ventricular Hypertrophy
Most effective at reducing LVH risk
ACE Inhibitor
s (e.g.
Lisinopril
)
Diuretic
s (e.g.
Chlorthalidone
)
Beta-Blocker
s (e.g.
Metoprolol
)
Least effective at reduced LVH risk
Prazosin
Clonidine
Diltiazem
Reference
Gottdiener (1997) Circulation 95:2007-14 [PubMed]
Management
Protocol
See
Hypertension Risk Stratification
See
Hypertension Reduction Goal
Management
Strategies
Hypertension General Measures
Antihypertensive Selection
Hypertension Combination Therapy
Hypertension Management for Specific Comorbid Diseases
Hypertension Management for Specific Populations
Hypertension Management for Specific Emergencies
References
(2000) Lancet 356:1955-64 [PubMed]
Type your search phrase here